Angiotensin receptor blockers and drug–drug interactions

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.1, 2005-01, pp. : 139-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug interactions with angiotensin receptor blockers

By Böhler Steffen Pittrow David Bramlage Peter Kirch Wilhelm

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 7-18

Informa Healthcare

Access to resources Recommend Favorite

Drug Interactions with Angiotensin Receptor Blockers: A Comparison with Other Antihypertensives

By Unger T. Kaschina E.

Drug Safety, Vol. 26, Iss. 10, 2003-01 ,pp. : 707-720

Adis International

Access to resources Recommend Favorite

Maraviroc potential drug-drug interactions

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Transporter-mediated drug––drug interactions

By Müüller Fabian Fromm Martin F

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 1017-1037

Future Medicine

Access to resources Recommend Favorite

Predicting inductive drug–drug interactions

By Liddle Christopher Robertson Graham R

Pharmacogenomics, Vol. 4, Iss. 2, 2003-03 ,pp. : 141-152

Future Medicine

Access to resources Recommend Favorite